A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 26, 2019

Primary Completion Date

April 5, 2021

Study Completion Date

January 10, 2022

Conditions
Ulcerative Colitis (UC)
Interventions
DRUG

Ravagalimab 600 mg

Ravagalimab 600 mg was administered intravenously (IV).

DRUG

Ravagalimab 300 mg

Ravagalimab 300 mg was administered subcutaneously (SC).

Trial Locations (34)

4032

Debreceni Egyetem Klinikai Kozpont /ID# 221952, Debrecen

6725

Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont /ID# 221576, Szeged

10117

Charite Universitaetsmedizin Berlin - Campus Mitte /ID# 207570, Berlin

20122

Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico /ID# 208504, Milan

24105

Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 207571, Kiel

28007

Hospital General Universitario Gregorio Maranon /ID# 204504, Madrid

28046

Hospital Universitario La Paz /ID# 210065, Madrid

41944

Kyungpook National University Hospital /ID# 209912, Daegu

42415

Yeungnam University Medical Center /ID# 210447, Daegu

54500

CHRU Nancy - Hôpitaux de Brabois /ID# 208133, Vandœuvre-lès-Nancy

60590

Universitaetsklinikum Frankfurt /ID# 207569, Frankfurt am Main

60637

The University of Chicago DCAM /ID# 207086, Chicago

78212

Clinical Associates in Research Therapeutics of America, LLC /ID# 204689, San Antonio

85724

Banner University Medical Cent /ID# 208392, Tucson

87131

Univ New Mexico /ID# 208817, Albuquerque

88100

University of Catanzaro /ID# 204546, Catanzaro

90048

TLC Clinical Research Inc /ID# 206626, Los Angeles

90712

Meridian Investigator Network /ID# 218568, Lakewood

92110

Hopital Beaujon /ID# 208129, Clichy

95817

UC Davis Medical Center /ID# 209402, Sacramento

92648-5994

Meridian Investigator Network /ID# 204646, Huntington Beach

92691-6306

Orange County Institute of Gastroenterology and Endoscopy /ID# 207405, Mission Viejo

60523-1245

Affinity Clinical Research /ID# 206211, Oak Brook

19104-2640

Penn Presbyterian Medical Center /ID# 206826, Philadelphia

37232-0011

Vanderbilt University Medical Center /ID# 204670, Nashville

M5G 1X5

Mount Sinai Hospital /ID# 206180, Toronto

06200

Chu de Nice-Hopital L'Archet Ii /Id# 208131, Nice

00168

Presidio Columbus-Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Un /ID# 204549, Rome

6229 HX

Maastricht Universitair Medisch Centrum /ID# 204428, Maastricht

3045 PM

Franciscus Gasthuis & Vlietland /ID# 206976, Rotterdam

5022 GC

Elisabeth Tweesteden Ziekenhuis /ID# 206272, Tilburg

08041

Hospital Santa Creu i Sant Pau /ID# 213259, Barcelona

G12 0XH

NHS Greater Glasgow and Clyde /ID# 206574, Glasgow

BT9 7AB

Belfast Health and Social Care Trust /ID# 206744, Belfast

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY